MDA’s research program awards grants to the world’s best scientists investigating promising theories and therapies that may accelerate treatments and cures for families living with muscle-debilitating diseases.
In 2016, we committed more than $17 million to new research. We’re now supporting 150 research projects worldwide.
Learn more about the research projects MDA is currently funding thanks to our supporters:
On Feb. 1, 2017, funding began for MDA’s latest round of grants, comprised of 29 projects targeting the neuromuscular diseases in MDA's program.
As part of MDA's basic research program, these grants focus on advancing basic science and generating ideas for potential drug therapies through projects initiated by the researchers themselves. Through the projects they fund we will learn more about the processes that drive the neuromuscular diseases MDA covers. We’ll identify, validate and optimize biological targets at which to aim future therapies. We’ll test potential therapeutic strategies, develop drug development tools and make other advances that will help pave the way to more clinical trials.
Twice a year these grant applications are reviewed by MDA’s Research Advisory Committee, which recommends the best projects for approval. Funding is approved by MDA’s Board of Directors.